LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
Early liquid biopsy testing did not significantly shorten the TTI in unselected patients referred for suspected advanced lung cancer. Nevertheless, it could reduce the TTI in patients eligible for systemic treatment, particularly for those with actionable alterations.
Authors
- P. Bombaron
- Acya Bizieux‐Thaminy
- Roland Schött (ORCID: https://orcid.org/0000-0002-7735-5366)
- Séverine Metzger (ORCID: https://orcid.org/0000-0002-9785-7486)
- D. Debieuvre (ORCID: https://orcid.org/0000-0002-8016-7956)
- Christodoulos Pipinikas (ORCID: https://orcid.org/0009-0007-7310-167X)
- Hubert Curcio (ORCID: https://orcid.org/0000-0003-3428-506X)
- Aurélie Swalduz (ORCID: https://orcid.org/0000-0002-8398-9373)
- Bana Ambasager
- P. Fournel (ORCID: https://orcid.org/0000-0002-3884-6816)
- M. Duruisseaux (ORCID: https://orcid.org/0000-0003-1495-0966)
- Camille Schiffler (ORCID: https://orcid.org/0000-0003-0633-8988)
- Sylvie Demolombe
- Nitzan Rosenfeld (ORCID: https://orcid.org/0000-0002-2825-4788)
- Pierre Saintigny (ORCID: https://orcid.org/0000-0002-8090-9323)
- L. Odier
- Sandra Ortiz‐Cuaran (ORCID: https://orcid.org/0000-0003-1152-5681)
- Annie Peytier
- S. Hominal
- Mathilde Donnat
- Maurice Pérol
- G Le Moël
- Claire Tissot
- Jean‐Marc Dot
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Babraham Institute (GB)
- Inserm (FR)
- Cancer Research UK (GB)
- Cancer Research UK Cambridge Center (GB)
- Institut de Cancérologie Strasbourg (FR)
- Hospices Civils de Lyon (FR)
- Centre Léon Bérard (FR)
- Hôpital Nord (FR)
- Centre François Baclesse (FR)
- Centre de Recherche en Cancérologie de Lyon (FR)
- Centre Hospitalier de la Côte Basque (FR)
- Hôpital Privé Jean Mermo (FR)
- Centre Hospitalier Annecy Genevois (FR)
- Médipole Garonne (FR)
- Hôpital Louis Pradel (FR)
- Centre Hospitalier Départemental Vendée (FR)
- Centre Hospitalier Public du Cotentin (FR)
- Hôpital Privé Jacques Cartier (FR)
- Groupe Hospitalier de la Région de Mulhouse et Sud Alsace (FR)
- Laboratoire de Biologie du Développement de Villefranche-sur-Mer (FR)
- Infirmerie Protestante (FR)
Publication Details
- Journal
- Journal of Thoracic Oncology
- Published
- 2024-12-16
- DOI
- https://doi.org/10.1016/j.jtho.2024.12.011
- Citations
- 10
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 2.93
Funders
- Institut National de la Santé et de la Recherche Médicale
- Institut National Du Cancer
- Direction Générale de l’offre de Soins